Bristol-Myers Squibb sell Morgan Stanley
Start price
12.12.25
/
50%
€44.58
Target price
12.12.26
-
Performance (%)
0.20%
Price
12.12.25
€44.67
Summary
This prediction is currently active. The SELL prediction by Morgan_Stanley for Bristol-Myers Squibb is nearly unchanged. This prediction currently runs until 12.12.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Bristol-Myers Squibb | 0.20% |
| iShares Core DAX® | 0.734% |
| iShares Nasdaq 100 | -2.686% |
| iShares Nikkei 225® | -2.261% |
| iShares S&P 500 | -1.346% |
Comments by Morgan_Stanley for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Morgan_Stanley for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.13
10.07.25
10.07.25
€28.95
10.07.26
10.07.26
8.61%
12.12.25
12.12.25
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€56.01
12.11.24
12.11.24
€36.70
12.11.25
12.11.25
-23.83%
13.11.25
13.11.25
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.80
27.10.23
27.10.23
€47.31
27.10.24
27.10.24
-3.66%
28.10.24
28.10.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.40
11.10.23
11.10.23
€52.70
11.10.24
11.10.24
-11.04%
12.10.24
12.10.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.70
19.07.23
19.07.23
€52.70
19.07.24
19.07.24
-30.56%
20.07.24
20.07.24

